Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

11

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Gap junction

3

Microphthalmia-associated transcription factor

3

Tyrosinase

3

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

6

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1992

4

2007

3

2014

3

2023

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Unknown

4

Acne

3

Hypertriglyceridemia

3

Type 2 diabetes mellitus

3

Ulcerative colitis

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Inactive ingredient

3

Preventing

3

Primary

3

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Hofstädter, P.G.

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

11

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

11

FDA UNII

11

PUBCHEM

11

EPA CompTox

10

ECHA (EC/EINECS)

8

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

7

Principal Form

4

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 11 results

First page disabled
Previous page disabled
1
Next page
Next page

CALCIUM PALMITATE

5792C4VMFZ

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2023

Class (Stereo):

CHEMICAL (ACHIRAL)

PALMITOLEIC ACID

209B6YPZ4I

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2014

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Microphthalmia-associated transcription factor

Conditions:

Type 2 diabetes mellitus

Hypertriglyceridemia

Ulcerative colitis

Palmitoleic acid, commonly known as omega-7, is a rare monounsatured fatty acid, which was generally reported to benefit the skin in promoting epithelialisation, and certain gynaecological problems (vaginal mycoses). Until now, sea buckthorn (Hippoph...

ae rhamnoides), a shrub widely found in Europe and Asia, and macadamia nuts have been the principal sources. Palmitoleic acid (PMA) has anti-inflammatory and antidiabetic activities. Palmitoleic acid is a gap junction uncoupler.

SEBACIC ACID

97AN39ICTC

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2007

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

ADIPIC ACID

76A0JE0FKJ

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1992

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Adipic acid has been incorporated into controlled-release formulation matrix tablets to obtain a pH-independent release for both weakly basic and weakly acidic drugs. It has also been incorporated into the polymeric coating of hydrophilic monolithic ...

systems to modulate the intragel pH, resulting in zero-order release of hydrophilic drugs. The disintegration at intestinal pH of the enteric polymer shellac has been reported to improve when adipic acid was used as a pore-forming agent without affecting release in the acidic media. Adipic acid is used to make bisobrin an antifibrinolytic.

PALMITELAIDIC ACID

65DJ825A3Z

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2014

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Microphthalmia-associated transcription factor

Conditions:

Type 2 diabetes mellitus

Hypertriglyceridemia

Ulcerative colitis

Palmitoleic acid, commonly known as omega-7, is a rare monounsatured fatty acid, which was generally reported to benefit the skin in promoting epithelialisation, and certain gynaecological problems (vaginal mycoses). Until now, sea buckthorn (Hippoph...

ae rhamnoides), a shrub widely found in Europe and Asia, and macadamia nuts have been the principal sources. Palmitoleic acid (PMA) has anti-inflammatory and antidiabetic activities. Palmitoleic acid is a gap junction uncoupler.

SODIUM PALMITOLEATE

9KXN90LI9Y

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2014

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Microphthalmia-associated transcription factor

Conditions:

Type 2 diabetes mellitus

Hypertriglyceridemia

Ulcerative colitis

Palmitoleic acid, commonly known as omega-7, is a rare monounsatured fatty acid, which was generally reported to benefit the skin in promoting epithelialisation, and certain gynaecological problems (vaginal mycoses). Until now, sea buckthorn (Hippoph...

ae rhamnoides), a shrub widely found in Europe and Asia, and macadamia nuts have been the principal sources. Palmitoleic acid (PMA) has anti-inflammatory and antidiabetic activities. Palmitoleic acid is a gap junction uncoupler.

DISODIUM SEBACATE

J3YU3MBH4Z

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2007

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

SEBACATE DIANION

PYO1TT7HG2

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2007

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

ADIPATE ION

U3YC62H084

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1992

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Adipic acid has been incorporated into controlled-release formulation matrix tablets to obtain a pH-independent release for both weakly basic and weakly acidic drugs. It has also been incorporated into the polymeric coating of hydrophilic monolithic ...

systems to modulate the intragel pH, resulting in zero-order release of hydrophilic drugs. The disintegration at intestinal pH of the enteric polymer shellac has been reported to improve when adipic acid was used as a pore-forming agent without affecting release in the acidic media. Adipic acid is used to make bisobrin an antifibrinolytic.

DIAMMONIUM ADIPATE

9VH76YE3HU

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1992

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Adipic acid has been incorporated into controlled-release formulation matrix tablets to obtain a pH-independent release for both weakly basic and weakly acidic drugs. It has also been incorporated into the polymeric coating of hydrophilic monolithic ...

systems to modulate the intragel pH, resulting in zero-order release of hydrophilic drugs. The disintegration at intestinal pH of the enteric polymer shellac has been reported to improve when adipic acid was used as a pore-forming agent without affecting release in the acidic media. Adipic acid is used to make bisobrin an antifibrinolytic.

Showing 1 - 10 of 11 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1